Bill · S. 1330· Senate(119-S-1330)
BRAIN Act
- Introduced
- 4/8/2025
- Last activity
- 4/8/2025 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Richard Blumenthal
- Cosponsors
- - 10 - 4
- Introduced
- In Committee
What this bill would do
The BRAIN Act aims to advance medical research to achieve breakthroughs in brain tumor treatment. The bill seeks to improve the adequacy and awareness of specialized cancer care. It establishes a research program called the Glioblastoma Therapeutics Network to evaluate therapeutic agents. Additionally, it funds research into brain tumor-related cellular immunotherapy, such as CAR-T. The legislation also creates a national awareness campaign regarding clinical trials and biomarker testing. Finally, it authorizes pilot programs to improve the monitoring and care of brain tumor survivors.
Yes· 3 of 9
Does this put more money into medical research?+8
The bill authorizes substantial funding for brain tumor research, including the Glioblastoma Therapeutics Network and immunotherapy.
Does this put more money into scientific research?+8
The bill allocates significant resources to advance medical research in brain tumor treatments.
Does this make health care easier to get in general?+7
The bill funds research, awareness, and survivorship programs to improve access to specialized brain tumor care.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Treatment Research: The creation of the Glioblastoma Therapeutics Network aims to improve the treatment of glioblastoma by evaluating therapeutic agents through early-phase clinical trials (Section 4).
-
Advancement in Immunotherapy: The bill supports the development of multi-institutional research for brain tumor-related cancer cellular immunotherapy, including CAR-T, for both adult and pediatric patients (Section 4).
-
Increased Information Access: The Secretary may establish a searchable website to make information regarding the existence, location, and description of covered biospecimen collections accessible to the public (Section 3).
-
Greater Public Awareness: A national campaign will increase knowledge among patients, caregivers, and health care providers regarding the importance of, and how to access, cancer clinical trials and biomarker testing (Section 5).
-
Targeted Outreach: The national campaign is required to include culturally and linguistically competent communications targeted toward specific populations at higher risk of cancer and rural communities (Section 5).
-
Enhanced Survivor Care: Pilot programs may develop and evaluate better approaches for monitoring and caring for brain tumor survivors, including multidisciplinary care and psychosocial support (Section 6).
Potential Negative Impacts for People
- Funding Withholding Risk: The Secretary may withhold funding from individuals or entities that commit repeated or egregious violations regarding the reporting of biospecimen collections (Section 3).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Increases Research Funding+8Improves Healthcare Access+7
- Demographic And Interest Groups
- Good For Children+6Good For Rural Residents+4Good For Young Adults+4
- Education And Technology
- Increases Scientific Research Funding+8
- Governance And Ideology
- Improves Government Transparency+5
- Social Issues And Justice
- Improves Racial Equity+4
- Environment Energy And Infrastructure
- Improves Rural Development+3
- 5/18/2026
- 2 Cosponsors added.
- 5/13/2026
- 1 Cosponsor added.
- 5/12/2026
- 2 Cosponsors added.
- 12/16/2025
- 1 Cosponsor added.
- 12/10/2025
- 1 Cosponsor added.
- 9/10/2025
- 1 Cosponsor added.
- 7/17/2025
- 1 Cosponsor added.
- 5/22/2025
- 2 Cosponsors added.
- 4/8/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 3 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Angela AlsobrooksDemocrat · Maryland
John BarrassoRepublican · Wyoming
Jim BanksRepublican · Indiana
Lisa Blunt RochesterDemocrat · Delaware
Christopher CoonsDemocrat · Delaware
Steve DainesRepublican · Montana
Kirsten GillibrandDemocrat · New York
Ruben GallegoDemocrat · Arizona
Mark KellyDemocrat · Arizona
John ReedDemocrat · Rhode Island
Mike RoundsRepublican · South Dakota
Adam SchiffDemocrat · California
Jeanne ShaheenDemocrat · New Hampshire
Chris Van HollenDemocrat · Maryland